Rob NoelIndependent Consultant at 55BiomarketsSpeaker
Profile
Rob has over 20 years experience in developing, implementing & commercialising new biomanufacturing technologies for plasma, vaccine, rPro, ADC and CGT. He is now consulting on quantifying manufacturing improvement projects.
Agenda Sessions
Paving the Path for Innovation: Success Factors for Novel Gene Therapies
, 12:30View SessionSustainability and Economics of Gene Therapy Vector Manufacturing – Prioiritsing Effort
, 16:30View Session